![Gabriele Cerrone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gabriele Cerrone
Fondateur chez
ACCM SCIE
Fortune : 64 M $ au 30/09/2026
Profil
Mr. Gabriele M.
Cerrone is a Non-Executive Chairman at OKYO Pharma Ltd., a Non-Executive Chairman at AccuStem Sciences, Inc., an Executive Chairman & Managing Partner at Panetta Partners Ltd., an Executive Chairman at Tiziana Life Sciences Ltd. (Bermuda), an Executive Chairman at Tiziana Life Sciences Ltd. (United Kingdom), a Chairman at Arna Therapeutics Ltd. and a Chairman at Biovitas Capital Ltd. He is on the Board of Directors at Gensignia IP Ltd. Mr. Cerrone was previously employed as a Chairman by Rasna Therapeutics, Inc. /Old/, a Chairman by Synergy Pharmaceuticals LLC, an Independent Director by Inhibitex LLC, a Chairman by FermaVir Pharmaceuticals LLC, a Chairman by Callisto Pharmaceuticals, Inc., a Senior Vice President-Investments by Oppenheimer & Co., Inc., a Managing Director-Investments by Barrington Capital Group LP, an Executive Chairman by Gensignia Life Sciences, Inc., an Executive Chairman by Gensignia Ltd., and a Co-Founder by Hepion Pharmaceuticals, Inc. He also served on the board at SIGA Technologies, Inc., Cardiff Oncology, Inc. and Pawfect Foods, Inc. He received his MBA from The Leonard N Stern School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TIZIANA LIFE SCIENCES LTD. 34,93 % | 21/07/2026 | 44 814 587 ( 34,93 % ) | 50 M $ | 30/09/2026 |
OKYO PHARMA LIMITED 20,72 % | 22/07/2026 | 10 873 916 ( 20,72 % ) | 14 M $ | 30/09/2026 |
ACCUSTEM SCIENCES INC 30,8 % | 13/06/2025 | 4 950 355 ( 30,8 % ) | 668 298 $ | 30/09/2026 |
Postes actifs de Gabriele Cerrone
| Sociétés | Poste | Début |
|---|---|---|
| WEST AFRICAN MINERALS CORP | Président | 07/01/2021 |
| ACCM SCIE | Fondateur | 05/06/2020 |
| TIZIANA LIFE SCIENCES LTD | Fondateur | 11/02/1998 |
Gensignia IP Ltd.
 Gensignia IP Ltd. Miscellaneous Commercial ServicesCommercial Services Provides professional, scientific and technical services | Directeur/Membre du Conseil | 23/04/2014 |
Biovitas Capital Ltd. | Fondateur | - |
Arna Therapeutics Ltd.
 Arna Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Fondateur | - |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Fondateur | 11/02/1998 |
Panetta Partners Ltd.
 Panetta Partners Ltd. Financial ConglomeratesFinance Private equity firm, primarily for technology companies | Président | 12/08/2013 |
Anciens postes connus de Gabriele Cerrone
| Sociétés | Poste | Fin |
|---|---|---|
Gensignia Ltd. | Fondateur | 29/04/2014 |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Gabriele Cerrone
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
52
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
SIGA Technologies, Inc.
 SIGA Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines and antibiotics | Health Technology |
Oppenheimer & Co., Inc.
 Oppenheimer & Co., Inc. Investment ManagersFinance Provides wealth and asset management, brokerage & investment banking services | Finance |
Panetta Partners Ltd.
Panetta Partners Ltd. Financial ConglomeratesFinance Private equity firm, primarily for technology companies | Finance |
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops novel therapeutics to treat cancer | Health Technology |
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Develops drugs | Health Technology |
Pawfect Foods, Inc.
 Pawfect Foods, Inc. Specialty StoresRetail Trade Sells pet food via the internet | Retail Trade |
OKYO Pharma Ltd.
 OKYO Pharma Ltd. BiotechnologyHealth Technology Develops next-generation therapeutics to improve the lives of patients suffering from inflammatory eye diseases | Health Technology |
Hepion Pharmaceuticals, Inc.
 Hepion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapy for treatment of chronic liver diseases | Health Technology |
Cardiff Oncology, Inc.
 Cardiff Oncology, Inc. Medical SpecialtiesHealth Technology Develops diagnostic products | Health Technology |
FermaVir Pharmaceuticals LLC
 FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Barrington Capital Group LP | |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops drugs to treat gastrointestinal disorders and diseases | Health Technology |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Health Technology |
Gensignia Ltd. | |
Arna Therapeutics Ltd.
Arna Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Commercial Services |
Biovitas Capital Ltd. | |
Gensignia Life Sciences, Inc.
 Gensignia Life Sciences, Inc. BiotechnologyHealth Technology Operates as a molecular diagnostics company which develop new molecular diagnosis techniques | Health Technology |
Rasna Therapeutics, Inc. /Old/
 Rasna Therapeutics, Inc. /Old/ Medical DistributorsDistribution Services Develops cancer drugs | Distribution Services |
Gensignia IP Ltd.
Gensignia IP Ltd. Miscellaneous Commercial ServicesCommercial Services Provides professional, scientific and technical services | Commercial Services |
AccuStem Sciences, Inc.
 AccuStem Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomics-based personalized medicines for breast cancer patients | Health Technology |
Tiziana Life Sciences Ltd.
 Tiziana Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
